Breast tomosynthesis: What do we know and where do we stand?

Autor: Patrice Taourel, Céline Orliac, Cécile Verheyden, I. Thomassin, Ingrid Millet, E. Pages, Caroline Mandoul
Přispěvatelé: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut Montpelliérain Alexander Grothendieck (IMAG), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Rok vydání: 2019
Předmět:
Image-Guided Biopsy
Quality Control
medicine.medical_specialty
Time Factors
Digital mammography
[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging
Breast imaging
Contrast Media
Medical Overuse
[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine
Mastectomy
Segmental
Radiation Dosage
Multimodal Imaging
Digital breast tomosynthesis
030218 nuclear medicine & medical imaging
03 medical and health sciences
Breast cancer screening
0302 clinical medicine
Breast cancer
Diagnosis
Cancer screening
Humans
Medicine
Mammography
Radiology
Nuclear Medicine and imaging
Medical physics
Early Detection of Cancer
Mass screening
Breast Density
Neoplasm Staging
Radiological and Ultrasound Technology
medicine.diagnostic_test
business.industry
General Medicine
medicine.disease
3. Good health
030220 oncology & carcinogenesis
Imaging technology
Female
Breast neoplasms
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Zdroj: Diagnostic and Interventional Imaging
Diagnostic and Interventional Imaging, Elsevier, 2019, 100 (10), pp.537-551. ⟨10.1016/j.diii.2019.07.012⟩
ISSN: 2211-5684
DOI: 10.1016/j.diii.2019.07.012
Popis: International audience; Digital breast tomosynthesis (DBT) is a new imaging technology that addresses the limitation caused by overlapping structures in conventional two-dimensional digital mammography owing to the acquisition of a series of low-dose projection images. This unique technique provides a dual benefit to patients screened for breast cancer. First, DBT increases the cancer detection rate mostly by highlighting architectural distortions and allowing better assessment of masses shape and margins. Second, DBT helps reduce recall rate by discarding asymmetries related to overlapping tissue. However, DBT is not included in the majority of cancer screening programs worldwide. Several issues still need to be addressed such as over-diagnosis and over-treatment, lack of reduction of interval breast cancer, quality control and storage, and radiation dose. In the diagnostic setting, DBT increases the diagnostic accuracy and reduces the number of indeterminate lesions in symptomatic women. Its aforementioned performances regarding asymmetries, masses and architectural distortions allow reducing the number of additional views while working-up a screening-detected lesion. Tumor size is also better assessed at DBT as well as multicentricity, two significant benefits in the staging of breast cancer. Finally, DBT allows a better analysis of scars and helps reduce the rate of indeterminate findings after surgery. Although somewhat limited by high breast density, DBT globally outperforms digital mammography in both screening and diagnostic breast imaging. Additional research is however needed, particularly on relevant screening outcomes. This review describes the main performances of breast DBT in breast cancer screening and diagnosis and the resulting consequences in both settings.
Databáze: OpenAIRE
Externí odkaz: